Clinical trial
Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia
NCT00538564 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia
- Lead sponsor
- Johns Hopkins University
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- November 30, 2006
- Completion date
- August 31, 2009
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
priapism, sickle cell anemia